A reverse pharmacology approach for developing an anti-malarial phytomedicine

Malaria Journal

Volumn 10, Issue SUPPL. 1, 2011, Pages

  Willcox, Merlin L ^a,b   Graz, Bertrand ^c   Falquet, Jacques ^b   Diakite, Chiaka ^d   Giani, Sergio ^e   Diallo, Drissa ^d  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b Research Initiative for Traditional Antimalarial Methods   (United Kingdom)

^c UNIVERSITY OF GENEVA   (Switzerland)

^d l'Inst Natl Rech Sante Publique   (Mali)

^e Aidemet NGO   (Mali)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOCRYPTOPINE; AMODIAQUINE; ANTIMALARIAL AGENT; ARGEMONE OIL; ARTEMISIA ANNUA EXTRACT; ARTEMISININ; BERBERINE; CHLOROQUINE; HERBACEOUS AGENT; PLANT MEDICINAL PRODUCT; PROTOBERBERINE DERIVATIVE; PROTOPINE; UNCLASSIFIED DRUG;

ANOGEISSUS LEIOCARPUS; ANTIMALARIAL ACTIVITY; ARGEMONE MEXICANA; ARTEMISIA ANNUA; CANTHIUM ACUTIFLORUM; CASSIA SIEBERIANA; DISEASE SEVERITY; DOSE RESPONSE; DRUG CYTOTOXICITY; DRUG DOSE ESCALATION; DRUG EFFICACY; DRUG RESEARCH; DRUG SAFETY; DRUG TOLERABILITY; DRUG TREATMENT FAILURE; ETHNOBOTANY; FERETIA APODANTHERA; HERBAL MEDICINE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; IC 50; MALARIA; MEDICINAL PLANT; NONHUMAN; OPILIA CELTIDIFOLIA; PAPAYA; PHARMACOLOGICAL SCIENCE; PHYTOCHEMISTRY; PHYTOMEDICINE; PLASMODIUM; PLASMODIUM BERGHEI INFECTION; PLASMODIUM MALARIAE INFECTION; QUALITY CONTROL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVERSE PHARMACOLOGY; REVIEW; RISK BENEFIT ANALYSIS; SECURINEGA VIROSA; SPONDIAS MOMBIN; THIN LAYER CHROMATOGRAPHY; UNSPECIFIED SIDE EFFECT;

ANTIMALARIALS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG DISCOVERY; HERBAL MEDICINE; HUMANS; MALARIA; MALI; PHARMACOLOGY, CLINICAL; PLANTS; PLANTS, MEDICINAL; PLASMODIUM;

EID: 79952763476     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-10-S1-S8     Document Type: Review

References (43)

1. Guidelines for the treatment of malaria. WHO, Geneva: World Health Organisation 2 2010
2. Artemisinin resistance: current status and scenarios for containment. AM Dondorp S Yeung L White C Nguon NPJ Day D Socheat L von Seidlein, Nature Reviews Microbiology 2010 8 272 280 10.1038/nrmicro2385 20208550
3. Innovative lead discovery strategies for tropical diseases. S Nwaka A Hudson, Nature Reviews Drug Discovery 2006 5 941 955 10.1038/nrd2144 17080030 (Pubitemid 44660607)
4. Advancing drug innovation for neglected diseases-criteria for lead progression. S Nwaka B Ramirez R Brun L Maes F Douglas R Ridley S Nwaka B Ramirez R Brun L Maes, et al. PLoS Neglected Tropical Diseases [electronic resource] 2009 3 440 10.1371/journal.pntd.0000440
5. The price of innovation: new estimates of drug development costs. JA DiMasi RW Hansen HG Grabowski, Journal of Health Economics 2003 22 151 185 10.1016/S0167-6296(02)00126-1 12606142 (Pubitemid 36279392)
6. Changshan (Dichroa febrifuga). Ancient Febrifuge And Modern Antimalarial: Lessons For Research From A Forgotten Tale. SH-l Lei G Bodeker, Traditional Medicinal Plants and Malaria Boca Raton: CRC Press, Willcox M, Bodeker G, Rasoanaivo P, 2004
7. Traditional medicine-inspired approaches to drug discovery: can Ayurveda show the way forward? B Patwardhan RA Mashelkar B Patwardhan RA Mashelkar, Drug Discovery Today 2009 14 804 811 10.1016/j.drudis.2009.05.009 19477288
8. Ethnopharmacology, sustainable development and cooperation: The importance of gathering clinical data during field surveys. B Graz J Falquet E Elisabetsky, Journal of Ethnopharmacology 2010 130 635 638 10.1016/j.jep.2010. 04.044 20466053
9. Screening of traditional herbal medicine: first, do a retrospective study, with correlation between diverse treatments used and reported patient outcome. B Graz D Diallo J Falquet M Willcox S Giani, Journal of Ethnopharmacology 2005 101 338 339 10.1016/j.jep.2005.07.008 16125888 (Pubitemid 41265644)
10. Malaria treatment in remote areas of Mali: use of modern and traditional medicines, patient outcome. D Diallo B Graz J Falquet AK Traore S Giani PP Mounkoro A Berthe M Sacko C Diakite, Trans R Soc Trop Med Hyg 2006 100 515 520 10.1016/j.trstmh.2005.08.003 16233907
11. Guidelines for the treatment of malaria. WHO, WHO/HTM/MAL/2006.1108 Geneva: WHO 2006
12. [Knowledge of traditional healers on malaria in Kendi (Bandiagara) and Finkolo (Sikasso) in Mali ]. D Diallo C Diakite PP Mounkoro D Sangare B Graz J Falquet S Giani, Mali Med 2007 22 1 8 19434974
13. Evaluation of Senegalese plants used in malaria treatment: focus on Chrozophora senegalensis. F Benoit-Vical PN Soh M Salery L Harguem C Poupat R Nongonierma, J Ethnopharmacol 2008 116 43 48 10.1016/j.jep.2007.10.033 18063330
14. Expert Committee on specifications for pharmaceutical preparations: Thirty-fourth report. WHO, Geneva: World Health Organisation 1996
15. Guidelines for the Appropriate Use of Herbal Medicines. WHO, Manila: WHO Regional Office for the Western Pacific 1998
16. Wild food plants and mushrooms of Uganda. AB Katende P Ssegawa A Birnie, Nairobi: Regional Land Management Unit, Sida 1999
17. General guidelines for methodologies on research and evaluation of traditional medicine. WHO, Geneva: World Health Organisation 2000
18. Guidelines for the pre-clinical evaluation of the safety of traditional herbal antimalarials. ML Willcox SK Gamaniel MG Matsabisa JR Randriasamimanana CON Wambebe P Rasoanaivo, Traditional Medicinal Plants and Malaria Boca Raton: CRC Press, Willcox M, Bodeker G, Rasoanaivo P, 2004
19. Google Scholar. http://scholar.google.com
20. Pubmed. http://www.ncbi.nlm.nih.gov/PubMed
21. WHO Monographs on selected medicinal plants. WHO, Geneva: World Health Organisation 1999
22. Herbal Medicines. J Barnes L Anderson J Phillipson, London: Pharmaceutical Press 3 2007
23. Poisonous Plants: A Handbook for Doctors, Pharmacists, Toxicologists, Biologists and Veterinarians. D Frohne H Pfände, Timber Press 2 2005
24. The Essential Guide to Herbal Safety. S Mills K Bone, St Louis, Missouri: Elsevier Churchill Livingstone 2005
25. Argemone mexicana poisoning: autopsy findings of two cases. SK Verma G Dev AK Tyagi S Goomber GV Jain, Forensic Science International 2001 115 135 141 10.1016/S0379-0738(00)00322-4 11056284
26. Activités antiplasmodiales in vitro de quelques plantes antipaludiques de la pharmacopée béninoise. T Adjobimey I Edayé L Lagnika J Gbenou M Moudachirou A Sanni, C R Chimie 2004 7 1023 1027 10.1016/j.crci.2003.10.022 (Pubitemid 39345185)
27. Contribution l'étude du traitement traditionnel du "suma" (paludisme). M Guindo, Universite de Bamako, Ecole Nationale de Médecine et de Pharmacie du Mali 1988
28. Dr K. M. Nadkarni's Indian Materia Medica. AK Nadkarni, Bombay: Popular Prakashan 3 1976
29. Plantas antimalaricas. S Blair A Correa B Madrigal CB Zuluaga HD Franco, Medellin, Colombia: Editorial Universidad de Antioquia 1991
30. Assessment and monitoring of antimalarial drug efficacy for the treatment of uncomplicated falciparum malaria. WHO, Geneva: World Health Organisation 2003
31. Guidelines for clinical studies on herbal antimalarials. M Willcox I Olanrewaju, Traditional Medicinal Plants and Malaria Boca Raton: CRC Press, Willcox M, Bodeker G, Rasoanaivo P, 2004 Hardman R (Series Editor)
32. Argemone mexicana decoction for the treatment of uncomplicated falciparum malaria. ML Willcox B Graz J Falquet O Sidibe M Forster D Diallo, Trans R Soc Trop Med Hyg 2007 101 1190 1198 10.1016/j.trstmh.2007.05.017 17920092 (Pubitemid 350028620)
33. Etude dArgemone mexicana Linn. dans le traitement traditionnel du paludisme non compliqué dans le village de Missidougou, région de Sikasso, Mali. O Sidibe, University of Bamako, Faculté de Médecine, Pharmacologie et Odonto-Stomatologie 2006
34. Rapport d'Expertise Toxicologique: Evaluation de la Toxicite et du pouvoir irritant d'un decocte aqueux des feuilles d'Argemone mexicana (Papaveraceae). IP Guissou, Ougadougou: Laboratoire de Biologie, Departement Medecine - Pharmacopee Traditionnelles, IRSS 2007 Book Rapport d'Expertise Toxicologique: Evaluation de la Toxicite et du pouvoir irritant d'un decocte aqueux des feuilles d'Argemone mexicana (Papaveraceae)
35. Argemone mexicana decoction versus Artesunate / Amodiaquine for the home-based management of malaria in Mali. Policy and public health implications. B Graz M Willcox C Diakite J Falquet F Dakouo O Sidibe S Giani D Diallo, Transactions of the Royal Society of Tropical Medicine & Hygiene 2010 104 33 41 10.1016/j.trstmh.2009.07.005
36. Early treatment of childhood fevers with pre-packaged antimalarial drugs in the home reduces severe malaria morbidity in Burkina Faso. SB Sirima A Konate AB Tiono N Convelbo S Cousens F Pagnoni, Trop Med Int Health 2003 8 133 139 10.1046/j.1365-3156.2003.00997.x 12581438 (Pubitemid 36269364)
37. Is parasite clearance clinically important after malaria treatment in a high transmission area? A 3-month follow-up of home-based management with herbal medicine or ACT. ML Willcox B Graz C Diakite J Falquet F Dackouo O Sidibe S Giani D Diallo, Transactions of the Royal Society of Tropical Medicine and Hygiene 2011 105 23 31 10.1016/j.trstmh.2010.10.003
38. Drug discovery in academia. AS Verkman, American Journal of Physiology - Cell Physiology 2004 286 465 474 10.1152/ajpcell.00397.2003 14761879
39. Investigation of antiplasmodial compounds from various plant extracts: Argemone mexicana L. (Papaveraceae), Licania octandra (Hoffmanns. ex. Roem & Schult) Kuntze (Chrysobalanaceae) and Syzygium cumini (L.) Skeels (Myrtaceae). CA Simoes-Pires, Universite de Geneve, Section des Sciences Pharmaceutiques, Laboratoire de Pharmacognosie et Phytochimie 2009
40. The Involvement of P-Glycoprotein in Berberine Absorption. G-Y Pan G-J Wang X-D Liu JP Fawcett Y-Y Xie, Pharmacology & Toxicology 2002 91 193 197 10.1034/j.1600-0773.2002.t01-1-910403.x 12530470 (Pubitemid 35216922)
41. Cryptolepis sanguinolenta. J Addae-Kyreme, Traditional Medicinal Plants and Malaria Boca Raton: CRC Press, Willcox ML, Bodeker G, Rasoanaivo P, 2004
42. Traditional herbal medicines for malaria. ML Willcox G Bodeker, BMJ 2004 329 1156 1159 15539672 10.1136/bmj.329.7475.1156 (Pubitemid 39524776)
43. Assessment of Therapeutic Efficacy of Antimalarial Drugs for Uncomplicated Falciparum Malaria in Areas with intense Transmission. WHO, WHO/MAL/96.1077 Geneva: World Health Organisation 1996